Phase II Pilot Study of Brentuximab Vedotin, Rituximab and Dose Attenuated CHP in Elderly Patients with DLBCL

IRB/UVA Tracking #
19731
Contact
Erica Stallard
Contact Email
Contact Phone
Phase
II
Primary purpose
Treatment
Cancer PI
Craig Portell
Status
OPEN TO ACCRUAL
Ages
Adult